Valstar Articles
FDA "approvable" letter for Indevus' Valstar
20 August 2007
Indevus to acquire Valera for $120M plus possible milestones
18 December 2006
Valera submits NDA on Supprelin-LA to US FDA
17 July 2006
Medeva confident about its future
12 February 1999
Medeva's Valstar launched in USA
4 February 1999
Medeva Files For European Approval Of Hepagene
27 October 1998
Medeva's Valstar Approved In USA
1 October 1998
Herceptin Heads Cancer Drugs Backed In USA
10 September 1998
US Advisory Panel Meetings
22 July 1998
Showing 1-11 of 11 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
